Phase III trials for the VLA1553 vaccine against chikungunya virus indicated promising results by inducing protective CHIKV neutralizing antibody titers…
Browsing: Emerging Disease > Chikungunya
Take a look at this month’s industry headlines including FDA warnings over hepatitis C drugs in patients with liver injury, a new infectious diseases strategy for the UK and priority review for Merck’s Ebola vaccine.
Take a look at this month’s industry headlines including an FDA approval for Zebraxa, new funding for chikungunya vaccine clinical…
A CDC report has shown that infection rates of diseases transmitted via the bite of an infected mosquito, tick or flea have tripled in the United States since the year 2004.
Blood samples from US athletes and staff who travelled to Rio de Janeiro, Brazil, for the 2016 Summer Games were not infected with Zika virus but tested positive for other viral infections, including West Nile Virus, dengue and chikungunya.
A chikungunya vaccine, developed by Themis Bioscience GmbH will be assessed for safety and efficacy in Phase II trials in Puerto Rico from August 2017.
Human mobility and globalization have brought new invasive species to other countries. In terms of environment and nature, some of…
Researchers have analyzed the clinical characteristics of Zika infection in Canadian travelers returning from the Americas, discovering that severe complications might be more common than previously estimated.
Researchers have identified a crucial mechanism by which the chikungunya virus infects host cells and mediates disease severity. This could present a future treatment target for both chikungunya and related viruses.